DNA Biomed Solns Free Cash Flow Generation Index

Latest as of December 2022: 1.00x

DNA Biomed Solns free cash flow generation index. DNA Biomed Solns (DNA) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of ILA394.50K represents 1% of operating cash flow (ILA394.50K).

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

ILA394.50K

ILA

Operating Cash Flow

ILA394.50K

ILA

Capital Expenditures

ILA0.00

ILA

Free Cash Flow Generation Index of DNA Biomed Solns (2024–2024)

Free cash flow generation index of DNA Biomed Solns from 2024 to 2024. Historical FCF Generation Index trend for DNA Biomed Solns across 1 annual periods. See DNA financial flexibility index to measure the company's free cash flow as a share of total liabilities.

DNA Biomed Solns Free Cash Flow Generation Index by Year (2024–2024)

DNA Biomed Solns free cash flow generation index by year from 2024 to 2024. Year-by-year Free Cash Flow Generation Index for DNA Biomed Solns. For the full cash flow conversion analysis, see DNA operating cash flow.

Year	FCG Index	Free Cash Flow (ILA)	Operating CF	Capital Expenditures	YoY Change
2024	1.00x	ILA1.61 Million	ILA1.61 Million	ILA0.00	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).